XML 59 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Mar. 29, 2014
Mar. 30, 2013
OPERATING ACTIVITIES    
Net loss $ (22,116) $ (47,986)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 48,998 46,218
Amortization 208,865 208,213
Non-cash interest expense 35,820 41,387
Stock-based compensation expense 26,098 31,079
Excess tax benefit related to equity awards (4,134) (4,437)
Deferred income taxes (164,788) (92,502)
Gain on sale of intellectual property   (53,884)
Fair value adjustments to contingent consideration   10,839
Fair value write-up of inventory sold   52,397
Asset impairment charges 33,308 47
Debt extinguishment loss 7,377 3,247
Cost-method equity investment impairment 3,705 1,733
Loss on disposal of property and equipment 3,438 2,198
Other (744) 1,976
Changes in operating assets and liabilities:    
Accounts receivable 21,544 8,627
Inventories (23,827) (3,719)
Prepaid income taxes 44,745 (16,700)
Prepaid expenses and other assets 9,769 1,225
Accounts payable (12,317) (12,939)
Accrued expenses and other liabilities (6,511) (11,799)
Deferred revenue 9,085 4,308
Net cash provided by operating activities 218,315 169,528
INVESTING ACTIVITIES    
Acquisition of a business   (3,918)
Payment of additional acquisition consideration   (16,808)
Proceeds from sale of business, net of cash transferred 2,431 86,250
Purchase of property and equipment (19,777) (25,888)
Increase in equipment under customer usage agreements (17,964) (20,955)
Net sales (purchases) of insurance contracts 13,841 (4,000)
Purchases of mutual funds (29,732)  
Sales of mutual funds 18,564  
Proceeds from sale of intellectual property   60,000
Purchase of cost-method equity investments   (3,625)
Increase in other assets (1,932) (4,951)
Net cash (used in) provided by investing activities (34,569) 66,105
FINANCING ACTIVITIES    
Repayment of long-term debt (562,500) (32,500)
Payment of debt issuance cost (2,446) (7,019)
Payment of contingent consideration   (42,433)
Payment of deferred acquisition consideration (4,965)  
Net proceeds from issuance of common stock pursuant to employee stock plans 53,718 37,623
Excess tax benefit related to equity awards 4,134 4,437
Payment of minimum tax withholdings on net share settlements of equity awards (9,163) (9,972)
Net cash used in financing activities (521,222) (49,864)
Effect of exchange rate changes on cash and cash equivalents (492) (1,203)
Net (decrease) increase in cash and cash equivalents (337,968) 184,566
Cash and cash equivalents, beginning of period 822,490 560,430
Cash and cash equivalents, end of period $ 484,522 $ 744,996